Royal Bank of Canada’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Royal Bank of Canada’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-213	Closed	-$6K	–	7368
2019 Q3	$6K	Sell	213 -249	-54%	-$4.03K	﹤0.01%	5998
2019 Q2	$7K	Buy	+462	New	+$4.39K	﹤0.01%	6200
2019 Q1	–	Sell	-137	Closed	-$1K	–	7301
2018 Q4	$1K	Sell	137 -63	-32%	-$1.01K	﹤0.01%	6667
2018 Q3	$4K	Sell	200 -200	-50%	-$4.76K	﹤0.01%	6384
2018 Q2	$12K	Sell	400 -3	-0.7%	-$82	﹤0.01%	5776
2018 Q1	$11K	Buy	403 +3	+0.8%	+$90	﹤0.01%	5695
2017 Q4	$12K	Sell	400 -1,058	-73%	-$29K	﹤0.01%	5811
2017 Q3	$36K	Buy	1,458 +1,208	+483%	+$28.6K	﹤0.01%	5621
2017 Q2	$6K	Buy	+250	New	+$5.26K	﹤0.01%	6008

Royal Bank of Canada's DOVA Position: Q4 2019 in Review

Royal Bank of Canada sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 213 shares — an estimated $6K sold.

Royal Bank of Canada first reported a position in DOVA in Q2 2017 and held it in 9 quarters. The position peaked at $36K in Q3 2017. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Royal Bank of Canada reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Royal Bank of Canada sold 213 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $6K.
Royal Bank of Canada first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 9 quarters.
Royal Bank of Canada's Dova Pharmaceuticals, Inc. Common Stock position peaked at $36K in Q3 2017.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.